Effects of Selenium and Melatonin on Ocular Ischemic Syndrome
- PMID: 31886253
- PMCID: PMC6925799
- DOI: 10.1155/2019/8080564
Effects of Selenium and Melatonin on Ocular Ischemic Syndrome
Abstract
Purpose: To determine the effects of selenium, melatonin, and selenium + melatonin administered for one month on anterior chamber (AC) malondialdehyde (MDA) and AC glutathione (GSH) levels in patients with ocular ischemic syndrome.
Materials and methods: Thirty-five patients were included in the study. Study groups were formed as follows: (1) control group, (2) ischemia group, (3) selenium + ischemia group, (4) melatonin + ischemia group, and (5) selenium + melatonin + ischemia group. AC samples were obtained. MDA and GSH levels in AC samples were evaluated.
Results: MDA levels were significantly increased in ischemia groups. Selenium and melatonin supplementation resulted in reduction of MDA levels and significant increase in GSH values.
Discussion: Increased lipid peroxidation associated with ischemia of the anterior segment has been prevented by selenium and melatonin supplementation. This trial is registered with ClinicalTrials.gov NCT04005222.
Copyright © 2019 Hande Hüsniye Telek.
Conflict of interest statement
The author declares that there are no conflicts of interest to declare.
References
-
- Gavrilenko A. V., Kuklin A. V., Kiseleva T. N. Efficacy of carotid endarterectomy in patients with stenosis of carotid arteries and acute vision impairment. Angiologia Sosudistaia Khirurgia. 2013;19(1):106–112. - PubMed
-
- Knox D. L. Ocular aspects of cervical vascular disease. Survey of Ophthalmology. 1969;13(5):245–262. - PubMed
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
